Valuation: Grape King Bio Ltd

Capitalization 15.04B 476M 412M 378M 356M 663M 45.38B 674M 4.5B 1.75B 21.95B 1.79B 1.75B 76.32B P/E ratio 2026 *
10.3x
P/E ratio 2027 * -
Enterprise value 15.04B 476M 412M 378M 356M 663M 45.38B 674M 4.5B 1.75B 21.95B 1.79B 1.75B 76.32B EV / Sales 2026 *
1.34x
EV / Sales 2027 * -
Free-Float
79.79%
Yield 2026 *
-
Yield 2027 * -
1 day-0.49%
1 week+0.50%
Current month+0.50%
1 month-9.78%
3 months-15.77%
6 months-21.92%
Current year-19.76%
1 week 99.7
Extreme 99.7
102.5
1 month 99.4
Extreme 99.4
114
Current year 99.4
Extreme 99.4
128.5
1 year 99.4
Extreme 99.4
138
3 years 99.4
Extreme 99.4
189
5 years 99.4
Extreme 99.4
191
10 years 99.4
Extreme 99.4
282
Manager TitleAgeSince
Chief Executive Officer - 2009-06-18
Director of Finance/CFO - 2013-12-31
Chief Tech/Sci/R&D Officer 75 2023-01-03
Director TitleAgeSince
Director/Board Member - 2021-07-14
Director/Board Member 70 2015-06-25
Director/Board Member - 1997-06-15
Change 5d. change 1-year change 3-years change Capi.($)
-0.49%+0.50%-23.40%-42.00% 476M
+3.46%+8.07%+45.46%+104.64% 14.39B
-1.66%-6.95%-60.48%+134.72% 5.12B
+0.84%-1.43%-16.98%-56.48% 2.38B
+3.30%+4.96% - - 1.66B
-0.40%-2.70%-18.43%-20.49% 1.33B
+0.35%-4.43%+48.44%-6.69% 1.18B
+2.14%+3.65%-64.00%-66.46% 1.08B
+0.85%+0.34%-2.50%+17.26% 1.06B
+0.92%+4.90%-85.62%-75.58% 1.02B
Average +0.93%+0.41%-19.72%-1.23% 2.97B
Weighted average by Cap. +1.77%+2.25%+5.94%+66.86%

Financials

2026 *2027 *
Net sales 11.19B 355M 307M 282M 265M 494M 33.78B 501M 3.35B 1.3B 16.34B 1.33B 1.3B 56.82B -
Net income 1.46B 46.37M 40.16M 36.85M 34.67M 64.57M 4.42B 65.58M 438M 170M 2.14B 174M 170M 7.43B -
Net Debt - -
Logo Grape King Bio Ltd
Grape King Bio Ltd is a Taiwan-based company mainly engaged in the manufacture and sale of healthcare products and beverages. The company operates through three business segments. The Direct Sales segment is engaged in the development and manufacture of related products for subsidiaries. The Distribution segment is engaged in the provision of own-brand products. The Original Equipment Manufacturer (OEM) segment is engaged in the OEM business in Taiwan and Shanghai. The main products include lactic acid bacteria products and other healthcare products, as well as beverage products, medicines and cosmetics. The Company operates in Taiwan, mainland China and other markets.
Employees
501
Date Price Change Volume
26-06-05 101.50 NT$ -0.49% 294,589
26-06-04 102.00 NT$ +0.49% 533,205
26-06-03 101.50 NT$ +1.00% 431,616
26-06-02 100.50 NT$ 0.00% 320,494
26-06-01 100.50 NT$ -0.50% 373,557
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
101.50TWD
Average target price
138.00TWD
Spread / Average Target
+35.96%

Quarterly revenue - Rate of surprise